Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Ketorolac for Post-THA Hypersensitivity
NCT00621530Phase 2Terminated
- Sponsor
- Wake Forest University
- Start
- Mar 2008
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ketorolac in postoperative pain and mechanical hypersensitivity, sponsored by Wake Forest University. Primary endpoint: Area of Hypersensitivity to Mechanical Stimuli Surrounding the Wound at 48 hours. Started Mar 2008; status: terminated.
02
Drugs
ketorolac
03
Conditions
postoperative painmechanical hypersensitivity
Beyond the preview
Go deeper on NCT00621530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00621530.